NUB1 protein localization as a prognostic modifier in ER-negative breast cancer
Cell Signaling · 14.02.2026 · 4 (1) · 28
DOI: 10.46439/signaling.4.092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Signaling, online erschienen am 14.02.2026. Verfasst von Ka-Liong Tan und 1 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Breast cancer remains a heterogeneous disease in which prognostic stratification, particularly within estrogen receptor (ER)-negative subtypes, remains clinically challenging. While genomic and transcriptomic profiling have advanced risk classification, protein-level regulation and subcellular localization are rarely incorporated into prognostic frameworks. NEDD8 ultimate buster 1 (NUB1) is a proteostasis-associated protein involved in degradation of ubiquitin-like modifiers and regulation of cell-cycle progression. Emerging evidence suggests that altered subcellular distribution of NUB1, rather than expression alone, associates with aggressive tumor behavior in ER-negative disease. In this editorial, we argue that NUB1 serves as a demonstrator protein illustrating how localization-dependent biology can refine prognostic stratification. Drawing on tissue-based outcome associations and paired primary–metastatic observations, we propose that loss of cytoplasmic NUB1 highlights a biologically distinct poor-outcome subset within ER-negative breast cancer. We further discuss validation priorities and practical considerations for incorporating localization-aware biomarkers into pathology workflows.
Zitieren
APA
Tan, K., & Pezzella, F. (2026). NUB1 protein localization as a prognostic modifier in ER-negative breast cancer. Cell Signaling, 4(1), 28. https://doi.org/10.46439/signaling.4.092
Vancouver
Tan K, Pezzella F. NUB1 protein localization as a prognostic modifier in ER-negative breast cancer. Cell Signaling. 2026;4(1):28. doi:10.46439/signaling.4.092
BibTeX
@article{Tan2026,
author = {Tan, Ka-Liong and Pezzella, Francesco},
title = {NUB1 protein localization as a prognostic modifier in ER-negative breast cancer},
journal = {Cell Signaling},
year = {2026},
volume = {4},
number = {1},
pages = {28},
doi = {10.46439/signaling.4.092}
}
EUVIMED